Regimen comprising GLP-1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre-mixed insulin regimen

Abstract Background Increasing evidence suggests that glucagon-like peptide 1 (GLP-1) receptor agonists (RA) can stabilize glycemic variability (GV) and interfere with eating behavior. This study compared the impact of insulin, GLP-1 RA, and dietary components on GV using professional continuous glu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi-Hsuan Lin, Chia-Hung Lin, Yu-Yao Huang, Hsin-Yun Chen, An-Shun Tai, Shih-Chen Fu, Sheng-Hwu Hsieh, Jui-Hung Sun, Szu-Tah Chen, Sheng-Hsuan Lin
Format:	Article
Language:	English
Published:	BMC 2022-12-01
Series:	European Journal of Medical Research
Subjects:	Continuous glucose monitoring Glucose variability Pre-mixed insulin GLP-1 receptor agonist Diet
Online Access:	https://doi.org/10.1186/s40001-022-00892-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Regimen comprising GLP-1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre-mixed insulin regimen

Similar Items